MedTrace Logo

Cell Transplant in Spinal Cord Injury Patients

NCT00816803 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-01-05

No results posted yet for this study

Summary

This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.

Conditions

  • Chronic Spinal Cord Injury

Interventions

PROCEDURE

Autologous bone marrow transplant

PROCEDURE

Physical therapy

Sponsors & Collaborators

  • Al-Azhar University

    collaborator OTHER

  • Medical Military Academy, Egypt

    collaborator UNKNOWN

  • Alexandria University

    collaborator OTHER

  • Cairo University

    lead OTHER

Study Design

Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
36 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816803 on ClinicalTrials.gov